Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired

Core Viewpoint - Glow Lifetech Corp. has achieved a significant reduction in its outstanding share purchase warrants and stock options, marking a milestone in simplifying its capital structure and reducing potential dilution [1][2]. Summary by Sections Reduction in Warrant and Option Overhang - In Q1 2026, the company reduced a total of 41,031,673 share purchase warrants and 5,025,000 stock options, with 30,123,371 warrants (76%) expiring unexercised and all stock options also expiring unexercised [2]. - Additionally, 10,908,302 warrants were exercised, generating total proceeds of $542,415, with approximately 89% of these exercises completed by management, directors, and long-term strategic shareholders [3]. Strengthening Capital Structure and Shareholder Alignment - Over the past twelve months, Glow has reduced its fully diluted share count by approximately 16.6%, driven by the expiry of warrants and stock options, indicating a focus on disciplined capital structure management [4]. - The combination of warrant expiry and exercise is seen as a meaningful step in simplifying the company's capital structure and improving overall equity quality [4]. Advancing a Stronger Financial Foundation - The reduction in outstanding warrants and options builds on previous balance sheet improvements, including achieving debt-free status and the first positive cash flow from operations, reinforcing Glow's financial foundation [6]. - These milestones support the company's ability to execute its growth strategy with increased flexibility and discipline [6]. Future Growth and Strategy - The company remains focused on maintaining capital efficiency, strengthening operating fundamentals, and delivering long-term sustainable value for shareholders as it expands its national footprint [7].